nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—melanoma	0.472	1	CbGaD
Indacaterol—CYP3A4—Temozolomide—melanoma	0.117	0.376	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—melanoma	0.0711	0.229	CbGbCtD
Indacaterol—CYP3A4—Vemurafenib—melanoma	0.0641	0.206	CbGbCtD
Indacaterol—ABCB1—Docetaxel—melanoma	0.0367	0.118	CbGbCtD
Indacaterol—CYP3A4—Docetaxel—melanoma	0.022	0.0708	CbGbCtD
Indacaterol—Musculoskeletal pain—Vemurafenib—melanoma	0.00413	0.0305	CcSEcCtD
Indacaterol—Atrial fibrillation—Vemurafenib—melanoma	0.00312	0.023	CcSEcCtD
Indacaterol—Infestation—Vemurafenib—melanoma	0.00228	0.0168	CcSEcCtD
Indacaterol—Infestation NOS—Vemurafenib—melanoma	0.00228	0.0168	CcSEcCtD
Indacaterol—Musculoskeletal pain—Temozolomide—melanoma	0.00211	0.0156	CcSEcCtD
Indacaterol—Oedema peripheral—Vemurafenib—melanoma	0.00202	0.0149	CcSEcCtD
Indacaterol—Connective tissue disorder—Vemurafenib—melanoma	0.00201	0.0148	CcSEcCtD
Indacaterol—Cardiac disorder—Vemurafenib—melanoma	0.0019	0.014	CcSEcCtD
Indacaterol—Mediastinal disorder—Vemurafenib—melanoma	0.00184	0.0136	CcSEcCtD
Indacaterol—Diabetes mellitus—Carmustine—melanoma	0.0018	0.0133	CcSEcCtD
Indacaterol—Malnutrition—Vemurafenib—melanoma	0.00178	0.0132	CcSEcCtD
Indacaterol—Myocardial ischaemia—Docetaxel—melanoma	0.00172	0.0127	CcSEcCtD
Indacaterol—Rhinorrhoea—Docetaxel—melanoma	0.00171	0.0126	CcSEcCtD
Indacaterol—Chest discomfort—Docetaxel—melanoma	0.00157	0.0116	CcSEcCtD
Indacaterol—Cough—Vemurafenib—melanoma	0.00155	0.0115	CcSEcCtD
Indacaterol—Bronchospasm—Bleomycin—melanoma	0.00152	0.0112	CcSEcCtD
Indacaterol—Oropharyngeal pain—Docetaxel—melanoma	0.00152	0.0112	CcSEcCtD
Indacaterol—Myalgia—Vemurafenib—melanoma	0.00152	0.0112	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00151	0.0111	CcSEcCtD
Indacaterol—Infection—Vemurafenib—melanoma	0.00144	0.0107	CcSEcCtD
Indacaterol—Nervous system disorder—Vemurafenib—melanoma	0.00143	0.0105	CcSEcCtD
Indacaterol—Hypokalaemia—Carmustine—melanoma	0.00142	0.0105	CcSEcCtD
Indacaterol—Skin disorder—Vemurafenib—melanoma	0.00141	0.0104	CcSEcCtD
Indacaterol—Pneumonia—Bleomycin—melanoma	0.00139	0.0103	CcSEcCtD
Indacaterol—Hypokalaemia—Temozolomide—melanoma	0.00138	0.0102	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00132	0.00978	CcSEcCtD
Indacaterol—Pneumonia—Dactinomycin—melanoma	0.0013	0.00956	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vemurafenib—melanoma	0.00126	0.00927	CcSEcCtD
Indacaterol—Hyperglycaemia—Carmustine—melanoma	0.00122	0.009	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Temozolomide—melanoma	0.00121	0.00897	CcSEcCtD
Indacaterol—Pneumonia—Carmustine—melanoma	0.00121	0.00895	CcSEcCtD
Indacaterol—Hyperglycaemia—Temozolomide—melanoma	0.00118	0.0087	CcSEcCtD
Indacaterol—Pneumonia—Temozolomide—melanoma	0.00117	0.00865	CcSEcCtD
Indacaterol—Infestation NOS—Temozolomide—melanoma	0.00117	0.0086	CcSEcCtD
Indacaterol—Infestation—Temozolomide—melanoma	0.00117	0.0086	CcSEcCtD
Indacaterol—Sinusitis—Temozolomide—melanoma	0.00109	0.00807	CcSEcCtD
Indacaterol—Hypersensitivity—Vemurafenib—melanoma	0.00107	0.00791	CcSEcCtD
Indacaterol—Oedema peripheral—Carmustine—melanoma	0.00107	0.00787	CcSEcCtD
Indacaterol—Connective tissue disorder—Carmustine—melanoma	0.00106	0.00785	CcSEcCtD
Indacaterol—Atrial fibrillation—Docetaxel—melanoma	0.00106	0.00783	CcSEcCtD
Indacaterol—Oedema peripheral—Temozolomide—melanoma	0.00103	0.00761	CcSEcCtD
Indacaterol—Pruritus—Vemurafenib—melanoma	0.00103	0.00759	CcSEcCtD
Indacaterol—Connective tissue disorder—Temozolomide—melanoma	0.00103	0.00759	CcSEcCtD
Indacaterol—Anaemia—Bleomycin—melanoma	0.000998	0.00736	CcSEcCtD
Indacaterol—Cardiac disorder—Temozolomide—melanoma	0.000971	0.00717	CcSEcCtD
Indacaterol—Dizziness—Vemurafenib—melanoma	0.000962	0.0071	CcSEcCtD
Indacaterol—Immune system disorder—Temozolomide—melanoma	0.000945	0.00697	CcSEcCtD
Indacaterol—Mediastinal disorder—Temozolomide—melanoma	0.000943	0.00696	CcSEcCtD
Indacaterol—Malnutrition—Carmustine—melanoma	0.000942	0.00696	CcSEcCtD
Indacaterol—Cough—Bleomycin—melanoma	0.000942	0.00695	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—melanoma	0.000931	0.00687	CcSEcCtD
Indacaterol—Chest pain—Bleomycin—melanoma	0.000919	0.00678	CcSEcCtD
Indacaterol—Myalgia—Bleomycin—melanoma	0.000919	0.00678	CcSEcCtD
Indacaterol—Rash—Vemurafenib—melanoma	0.000917	0.00677	CcSEcCtD
Indacaterol—Dermatitis—Vemurafenib—melanoma	0.000916	0.00676	CcSEcCtD
Indacaterol—Headache—Vemurafenib—melanoma	0.000911	0.00672	CcSEcCtD
Indacaterol—Malnutrition—Temozolomide—melanoma	0.000911	0.00672	CcSEcCtD
Indacaterol—Nasopharyngitis—Docetaxel—melanoma	0.000899	0.00664	CcSEcCtD
Indacaterol—Tremor—Carmustine—melanoma	0.000883	0.00652	CcSEcCtD
Indacaterol—Infection—Bleomycin—melanoma	0.000875	0.00646	CcSEcCtD
Indacaterol—Anaemia—Carmustine—melanoma	0.000871	0.00643	CcSEcCtD
Indacaterol—Nausea—Vemurafenib—melanoma	0.000864	0.00638	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—melanoma	0.000857	0.00633	CcSEcCtD
Indacaterol—Bronchospasm—Docetaxel—melanoma	0.000855	0.00631	CcSEcCtD
Indacaterol—Tremor—Temozolomide—melanoma	0.000853	0.0063	CcSEcCtD
Indacaterol—Angina pectoris—Docetaxel—melanoma	0.000847	0.00625	CcSEcCtD
Indacaterol—Anaemia—Temozolomide—melanoma	0.000842	0.00621	CcSEcCtD
Indacaterol—Vertigo—Temozolomide—melanoma	0.000818	0.00604	CcSEcCtD
Indacaterol—Infection—Dactinomycin—melanoma	0.000816	0.00603	CcSEcCtD
Indacaterol—Palpitations—Temozolomide—melanoma	0.000805	0.00594	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Bleomycin—melanoma	0.000803	0.00592	CcSEcCtD
Indacaterol—Myalgia—Carmustine—melanoma	0.000802	0.00592	CcSEcCtD
Indacaterol—Chest pain—Carmustine—melanoma	0.000802	0.00592	CcSEcCtD
Indacaterol—Cough—Temozolomide—melanoma	0.000795	0.00587	CcSEcCtD
Indacaterol—Paraesthesia—Bleomycin—melanoma	0.000791	0.00584	CcSEcCtD
Indacaterol—Dyspnoea—Bleomycin—melanoma	0.000786	0.0058	CcSEcCtD
Indacaterol—Pneumonia—Docetaxel—melanoma	0.000779	0.00575	CcSEcCtD
Indacaterol—Myalgia—Temozolomide—melanoma	0.000775	0.00572	CcSEcCtD
Indacaterol—Infestation—Docetaxel—melanoma	0.000775	0.00572	CcSEcCtD
Indacaterol—Infestation NOS—Docetaxel—melanoma	0.000775	0.00572	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00077	0.00568	CcSEcCtD
Indacaterol—Infection—Carmustine—melanoma	0.000764	0.00564	CcSEcCtD
Indacaterol—Dry mouth—Temozolomide—melanoma	0.000758	0.0056	CcSEcCtD
Indacaterol—Tachycardia—Carmustine—melanoma	0.000751	0.00554	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000749	0.00553	CcSEcCtD
Indacaterol—Infection—Temozolomide—melanoma	0.000738	0.00545	CcSEcCtD
Indacaterol—Nervous system disorder—Temozolomide—melanoma	0.000729	0.00538	CcSEcCtD
Indacaterol—Skin disorder—Temozolomide—melanoma	0.000722	0.00533	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Carmustine—melanoma	0.000701	0.00517	CcSEcCtD
Indacaterol—Paraesthesia—Carmustine—melanoma	0.000691	0.0051	CcSEcCtD
Indacaterol—Dyspnoea—Carmustine—melanoma	0.000686	0.00506	CcSEcCtD
Indacaterol—Oedema peripheral—Docetaxel—melanoma	0.000685	0.00506	CcSEcCtD
Indacaterol—Connective tissue disorder—Docetaxel—melanoma	0.000684	0.00505	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Temozolomide—melanoma	0.000677	0.005	CcSEcCtD
Indacaterol—Paraesthesia—Temozolomide—melanoma	0.000667	0.00493	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Carmustine—melanoma	0.000664	0.0049	CcSEcCtD
Indacaterol—Dyspnoea—Temozolomide—melanoma	0.000663	0.00489	CcSEcCtD
Indacaterol—Hypersensitivity—Bleomycin—melanoma	0.000649	0.00479	CcSEcCtD
Indacaterol—Cardiac disorder—Docetaxel—melanoma	0.000646	0.00477	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Temozolomide—melanoma	0.000642	0.00474	CcSEcCtD
Indacaterol—Immune system disorder—Docetaxel—melanoma	0.000628	0.00464	CcSEcCtD
Indacaterol—Mediastinal disorder—Docetaxel—melanoma	0.000627	0.00463	CcSEcCtD
Indacaterol—Pruritus—Bleomycin—melanoma	0.000623	0.0046	CcSEcCtD
Indacaterol—Malnutrition—Docetaxel—melanoma	0.000606	0.00447	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—melanoma	0.000605	0.00447	CcSEcCtD
Indacaterol—Muscle spasms—Docetaxel—melanoma	0.000582	0.0043	CcSEcCtD
Indacaterol—Hypersensitivity—Carmustine—melanoma	0.000567	0.00418	CcSEcCtD
Indacaterol—Anaemia—Docetaxel—melanoma	0.00056	0.00413	CcSEcCtD
Indacaterol—Rash—Bleomycin—melanoma	0.000556	0.0041	CcSEcCtD
Indacaterol—Dermatitis—Bleomycin—melanoma	0.000555	0.0041	CcSEcCtD
Indacaterol—Hypersensitivity—Temozolomide—melanoma	0.000548	0.00404	CcSEcCtD
Indacaterol—Palpitations—Docetaxel—melanoma	0.000535	0.00395	CcSEcCtD
Indacaterol—Cough—Docetaxel—melanoma	0.000528	0.0039	CcSEcCtD
Indacaterol—Pruritus—Temozolomide—melanoma	0.000526	0.00388	CcSEcCtD
Indacaterol—Nausea—Bleomycin—melanoma	0.000523	0.00386	CcSEcCtD
Indacaterol—Rash—Dactinomycin—melanoma	0.000518	0.00382	CcSEcCtD
Indacaterol—Chest pain—Docetaxel—melanoma	0.000516	0.00381	CcSEcCtD
Indacaterol—Myalgia—Docetaxel—melanoma	0.000516	0.00381	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000512	0.00378	CcSEcCtD
Indacaterol—Dizziness—Carmustine—melanoma	0.000509	0.00375	CcSEcCtD
Indacaterol—Dry mouth—Docetaxel—melanoma	0.000504	0.00372	CcSEcCtD
Indacaterol—Dizziness—Temozolomide—melanoma	0.000491	0.00363	CcSEcCtD
Indacaterol—Infection—Docetaxel—melanoma	0.000491	0.00362	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—melanoma	0.000488	0.0036	CcSEcCtD
Indacaterol—Rash—Carmustine—melanoma	0.000485	0.00358	CcSEcCtD
Indacaterol—Nervous system disorder—Docetaxel—melanoma	0.000485	0.00358	CcSEcCtD
Indacaterol—Dermatitis—Carmustine—melanoma	0.000484	0.00358	CcSEcCtD
Indacaterol—Tachycardia—Docetaxel—melanoma	0.000482	0.00356	CcSEcCtD
Indacaterol—Headache—Carmustine—melanoma	0.000482	0.00356	CcSEcCtD
Indacaterol—Skin disorder—Docetaxel—melanoma	0.00048	0.00354	CcSEcCtD
Indacaterol—Rash—Temozolomide—melanoma	0.000469	0.00346	CcSEcCtD
Indacaterol—Dermatitis—Temozolomide—melanoma	0.000468	0.00346	CcSEcCtD
Indacaterol—Headache—Temozolomide—melanoma	0.000466	0.00344	CcSEcCtD
Indacaterol—Nausea—Carmustine—melanoma	0.000457	0.00337	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Docetaxel—melanoma	0.00045	0.00332	CcSEcCtD
Indacaterol—Paraesthesia—Docetaxel—melanoma	0.000444	0.00328	CcSEcCtD
Indacaterol—Nausea—Temozolomide—melanoma	0.000441	0.00326	CcSEcCtD
Indacaterol—Dyspnoea—Docetaxel—melanoma	0.000441	0.00325	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Docetaxel—melanoma	0.000427	0.00315	CcSEcCtD
Indacaterol—Hypersensitivity—Docetaxel—melanoma	0.000364	0.00269	CcSEcCtD
Indacaterol—Pruritus—Docetaxel—melanoma	0.00035	0.00258	CcSEcCtD
Indacaterol—Dizziness—Docetaxel—melanoma	0.000327	0.00241	CcSEcCtD
Indacaterol—Rash—Docetaxel—melanoma	0.000312	0.0023	CcSEcCtD
Indacaterol—Dermatitis—Docetaxel—melanoma	0.000311	0.0023	CcSEcCtD
Indacaterol—Headache—Docetaxel—melanoma	0.00031	0.00229	CcSEcCtD
Indacaterol—Nausea—Docetaxel—melanoma	0.000294	0.00217	CcSEcCtD
Indacaterol—ADRB1—Signaling Pathways—FLT1—melanoma	2.8e-05	0.000343	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ABCB1—melanoma	2.8e-05	0.000342	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	2.78e-05	0.000339	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GAB2—melanoma	2.76e-05	0.000337	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GNA11—melanoma	2.76e-05	0.000337	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FLT1—melanoma	2.74e-05	0.000335	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.74e-05	0.000335	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	2.72e-05	0.000332	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.68e-05	0.000328	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.68e-05	0.000328	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCR4—melanoma	2.65e-05	0.000324	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HDAC2—melanoma	2.65e-05	0.000324	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FOXO4—melanoma	2.65e-05	0.000324	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GNAQ—melanoma	2.62e-05	0.00032	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FOXO4—melanoma	2.59e-05	0.000316	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HDAC2—melanoma	2.59e-05	0.000316	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCR4—melanoma	2.59e-05	0.000316	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PRKCA—melanoma	2.58e-05	0.000315	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GNAQ—melanoma	2.56e-05	0.000313	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ERCC2—melanoma	2.56e-05	0.000312	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.55e-05	0.000312	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.53e-05	0.000309	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	2.52e-05	0.000308	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	2.47e-05	0.000301	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SYK—melanoma	2.46e-05	0.000301	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PLA2G6—melanoma	2.45e-05	0.000299	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	2.44e-05	0.000298	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT3—melanoma	2.42e-05	0.000295	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ITGAV—melanoma	2.42e-05	0.000295	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NGFR—melanoma	2.42e-05	0.000295	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PLCB4—melanoma	2.42e-05	0.000295	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SYK—melanoma	2.41e-05	0.000294	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	2.39e-05	0.000292	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ITGAV—melanoma	2.36e-05	0.000289	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT3—melanoma	2.36e-05	0.000289	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NGFR—melanoma	2.36e-05	0.000289	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.33e-05	0.000284	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC6A11—melanoma	2.27e-05	0.000277	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIP4K2A—melanoma	2.27e-05	0.000277	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.25e-05	0.000275	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SOCS1—melanoma	2.24e-05	0.000273	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	2.23e-05	0.000273	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—S100B—melanoma	2.23e-05	0.000273	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	2.22e-05	0.000271	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTAP—melanoma	2.21e-05	0.00027	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—VCAN—melanoma	2.2e-05	0.000269	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SOCS1—melanoma	2.19e-05	0.000267	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	2.18e-05	0.000267	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—S100B—melanoma	2.18e-05	0.000267	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	2.17e-05	0.000265	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB4—melanoma	2.14e-05	0.000261	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	2.13e-05	0.00026	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN2B—melanoma	2.12e-05	0.000258	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB4—melanoma	2.09e-05	0.000255	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	2.08e-05	0.000254	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN2B—melanoma	2.07e-05	0.000253	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD86—melanoma	2.05e-05	0.00025	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	2.05e-05	0.00025	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EDN1—melanoma	2.03e-05	0.000248	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CG—melanoma	2.02e-05	0.000247	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD86—melanoma	2e-05	0.000245	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	2e-05	0.000244	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EDN1—melanoma	1.99e-05	0.000243	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CSF2—melanoma	1.98e-05	0.000242	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGF1—melanoma	1.98e-05	0.000242	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PHGDH—melanoma	1.97e-05	0.000241	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—LUM—melanoma	1.97e-05	0.000241	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2—melanoma	1.96e-05	0.000239	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPARG—melanoma	1.95e-05	0.000238	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—E2F1—melanoma	1.94e-05	0.000237	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGF1—melanoma	1.94e-05	0.000237	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CSF2—melanoma	1.94e-05	0.000237	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	1.93e-05	0.000236	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HPSE—melanoma	1.93e-05	0.000236	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFRA—melanoma	1.92e-05	0.000235	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2—melanoma	1.91e-05	0.000234	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ITGB3—melanoma	1.9e-05	0.000232	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PRKCA—melanoma	1.9e-05	0.000232	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.9e-05	0.000232	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—E2F1—melanoma	1.9e-05	0.000232	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CUBN—melanoma	1.9e-05	0.000232	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	1.89e-05	0.000231	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFRA—melanoma	1.88e-05	0.00023	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SPP1—melanoma	1.87e-05	0.000228	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PRKCA—melanoma	1.86e-05	0.000227	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ITGB3—melanoma	1.86e-05	0.000227	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAP2K2—melanoma	1.86e-05	0.000227	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL8—melanoma	1.86e-05	0.000227	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP17A1—melanoma	1.85e-05	0.000227	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SDHD—melanoma	1.83e-05	0.000224	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CSPG4—melanoma	1.83e-05	0.000224	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BSG—melanoma	1.83e-05	0.000224	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SPP1—melanoma	1.83e-05	0.000223	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAP2K2—melanoma	1.82e-05	0.000222	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL8—melanoma	1.82e-05	0.000222	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CD—melanoma	1.78e-05	0.000217	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2—melanoma	1.78e-05	0.000217	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPAM—melanoma	1.77e-05	0.000217	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TERT—melanoma	1.77e-05	0.000216	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RAC1—melanoma	1.76e-05	0.000215	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—melanoma	1.75e-05	0.000214	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GNA11—melanoma	1.75e-05	0.000214	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2—melanoma	1.74e-05	0.000212	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TERT—melanoma	1.73e-05	0.000211	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RAC1—melanoma	1.73e-05	0.000211	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.72e-05	0.00021	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—FASN—melanoma	1.71e-05	0.000209	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIF1A—melanoma	1.69e-05	0.000207	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC5A5—melanoma	1.69e-05	0.000206	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIF1A—melanoma	1.66e-05	0.000202	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GNAQ—melanoma	1.63e-05	0.000199	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CD44—melanoma	1.63e-05	0.000199	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KDR—melanoma	1.62e-05	0.000198	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KDR—melanoma	1.58e-05	0.000193	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP1B1—melanoma	1.56e-05	0.000191	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FN1—melanoma	1.56e-05	0.00019	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CB—melanoma	1.55e-05	0.000189	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—melanoma	1.53e-05	0.000187	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH1—melanoma	1.52e-05	0.000186	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FN1—melanoma	1.52e-05	0.000186	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PLA2G6—melanoma	1.51e-05	0.000184	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD80—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KIT—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APC—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGF—melanoma	1.47e-05	0.00018	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD80—melanoma	1.46e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KIT—melanoma	1.46e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APC—melanoma	1.46e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.46e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.46e-05	0.000178	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGF—melanoma	1.44e-05	0.000176	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.43e-05	0.000174	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BRAF—melanoma	1.4e-05	0.000171	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.4e-05	0.000171	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BRAF—melanoma	1.37e-05	0.000167	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF1—melanoma	1.36e-05	0.000167	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—VCAN—melanoma	1.35e-05	0.000165	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTEN—melanoma	1.34e-05	0.000163	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF1—melanoma	1.34e-05	0.000163	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.33e-05	0.000162	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.33e-05	0.000162	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.32e-05	0.000161	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.31e-05	0.00016	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.3e-05	0.000159	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.29e-05	0.000158	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.28e-05	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.28e-05	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.27e-05	0.000155	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.25e-05	0.000153	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGF2—melanoma	1.25e-05	0.000153	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGF2—melanoma	1.23e-05	0.00015	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PRKCA—melanoma	1.18e-05	0.000145	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.18e-05	0.000144	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MDM2—melanoma	1.17e-05	0.000143	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ERCC2—melanoma	1.17e-05	0.000143	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.16e-05	0.000141	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MDM2—melanoma	1.15e-05	0.00014	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP17A1—melanoma	1.14e-05	0.00014	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.14e-05	0.00014	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.13e-05	0.000138	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.12e-05	0.000136	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL8—melanoma	1.1e-05	0.000134	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HRAS—melanoma	1.09e-05	0.000133	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GNA11—melanoma	1.08e-05	0.000132	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL8—melanoma	1.07e-05	0.000131	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.07e-05	0.000131	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HRAS—melanoma	1.07e-05	0.00013	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.06e-05	0.00013	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—FASN—melanoma	1.06e-05	0.000129	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1B—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—melanoma	1.04e-05	0.000127	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC5A5—melanoma	1.04e-05	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—melanoma	1.04e-05	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—melanoma	1.03e-05	0.000126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2—melanoma	1.03e-05	0.000125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCND1—melanoma	1.02e-05	0.000125	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—melanoma	1.02e-05	0.000125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.01e-05	0.000124	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GNAQ—melanoma	1e-05	0.000123	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CD44—melanoma	1e-05	0.000123	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCND1—melanoma	1e-05	0.000122	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—melanoma	9.93e-06	0.000121	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CTNNB1—melanoma	9.91e-06	0.000121	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1A—melanoma	9.89e-06	0.000121	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTEN—melanoma	9.87e-06	0.000121	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NFKB1—melanoma	9.82e-06	0.00012	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—melanoma	9.71e-06	0.000119	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1A—melanoma	9.68e-06	0.000118	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTEN—melanoma	9.65e-06	0.000118	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—melanoma	9.63e-06	0.000118	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP1B1—melanoma	9.62e-06	0.000117	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NFKB1—melanoma	9.61e-06	0.000117	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—melanoma	9.44e-06	0.000115	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—melanoma	9.42e-06	0.000115	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CG—melanoma	9.27e-06	0.000113	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARG—melanoma	8.94e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—melanoma	8.91e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—melanoma	8.83e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NRAS—melanoma	8.81e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—melanoma	8.72e-06	0.000107	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—melanoma	8.63e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NRAS—melanoma	8.61e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK3—melanoma	8.43e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK3—melanoma	8.25e-06	0.000101	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—melanoma	8.2e-06	0.0001	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CD—melanoma	8.15e-06	9.95e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—melanoma	8.04e-06	9.82e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK1—melanoma	8.02e-06	9.8e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—melanoma	8.02e-06	9.8e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—melanoma	8.02e-06	9.8e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCB1—melanoma	7.92e-06	9.67e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK1—melanoma	7.85e-06	9.59e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—melanoma	7.85e-06	9.59e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—melanoma	7.71e-06	9.42e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—melanoma	7.58e-06	9.26e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—melanoma	7.41e-06	9.05e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PRKCA—melanoma	7.29e-06	8.9e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ERCC2—melanoma	7.23e-06	8.83e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CB—melanoma	7.1e-06	8.67e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—melanoma	7.04e-06	8.59e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—melanoma	6.96e-06	8.5e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—melanoma	6.81e-06	8.32e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—melanoma	6.74e-06	8.23e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—melanoma	6.59e-06	8.05e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRAS—melanoma	6.44e-06	7.87e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRAS—melanoma	6.3e-06	7.7e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—melanoma	6.17e-06	7.53e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTEN—melanoma	6.14e-06	7.49e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—melanoma	6.03e-06	7.37e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CG—melanoma	5.71e-06	6.97e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—melanoma	5.69e-06	6.95e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—melanoma	5.56e-06	6.8e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARG—melanoma	5.51e-06	6.73e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CD—melanoma	5.02e-06	6.13e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—melanoma	4.96e-06	6.05e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CB—melanoma	4.38e-06	5.34e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—melanoma	4.34e-06	5.29e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—melanoma	4.33e-06	5.29e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTEN—melanoma	3.78e-06	4.62e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—melanoma	3.54e-06	4.32e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—melanoma	2.67e-06	3.26e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—melanoma	2.18e-06	2.66e-05	CbGpPWpGaD
